Stefanie Flückiger-Mangual, Co-founder & CEO will be presenting TOLREMO Therapeutics AG at the upcoming Biotech in Europe Forum.

e-Meet TOLREMO Therapeutics AG at #Sachs_BEF

More info @ https://t.co/XI3zEYGyl2 pic.twitter.com/D1ovot17Wr

— Sachs Associates (@SachsAssociates) September 10, 2020